This edition of Citizen Today includes insights on the education market from Parthenon-EY Managing Directors Amit Garga, Karan Khemka, Haven Ladd, Robert Lytle and Matthew Robb.
Software companies of all shapes and sizes should ask themselves if they are in the right position to compete in a SaaS-driven environment.
Inorganic strategies are driving the digital agenda in life sciences.
Watch Parthenon-EY Managing Director and Co-head of Health Care Dan Shoenholz and EY Partner Arda Ural discuss growth themes in medtech in 2017.
Managing Director Liz Lippert and Managing Director and Co-head of Private Equity Andres Saenz discuss opportunities in the pet industry for PE investors.
Parthenon-EY’s in-depth research shows where and how companies can harness shareholder activists’ tactics for competitive advantage.
New technologies, customers and competition are forcing — and enabling — biopharmaceutical companies to find novel ways to create and capture value.
The Parthenon-EY team is committed to bringing unconventional yet pragmatic thinking together with our clients’ smarts to deliver actionable strategies for real impact in today’s complex business landscape.